Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2020

27.11.2019 | Original Article

Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease

verfasst von: Amnon Sonnenberg, Kevin O. Turner, Robert M. Genta

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

Compromise of the gastric acid barrier may facilitate bacterial invasion of the lower intestinal tract and influence the occurrence of inflammatory bowel disease (IBD). Our study tested the associations between histopathologic changes in the upper and lower gastrointestinal tract in patients undergoing bidirectional endoscopy.

Methods

The Inform Diagnostics database is a national electronic repository of histopathologic records of patients distributed throughout the entire USA. A case–control study among 302,061 patients, of whom 13,943 harbored IBD, evaluated whether the occurrence of Crohn’s disease or ulcerative colitis was influenced by the presence of various upper gastrointestinal diagnoses associated with lowered gastric acid output. The influence of individual risk factors on the occurrence of colonic disease was expressed as odds ratios with their 95% confidence intervals.

Results

The odds ratio for Crohn’s disease being associated with gastric H. pylori was 0.30 (0.24–0.37), with intestinal metaplasia 0.30 (0.24–0.39), with fundic gland polyps 0.42 (0.35–0.50), with gastric hyperplastic polyps 0.35 (0.23–0.51), with Barrett’s metaplasia 0.19 (0.14–0.24), and with reflux esophagitis 0.46 (0.42–0.51). The odds ratio for ulcerative colitis being associated with gastric H. pylori was 0.58 (0.50–0.67), with intestinal metaplasia 0.39 (0.32–0.47), with fundic gland polyps 0.61 (0.53–0.71), with gastric hyperplastic polyps 0.64 (0.49–0.84), with Barrett’s metaplasia 0.50 (0.43–0.59), and with reflux esophagitis 0.77 (0.71–0.84).

Conclusions

A diminished gastric acid barrier function, as evidenced by various upper gastrointestinal diseases associated with lowered gastric acid output, may exert a protective influence against the development of inflammatory bowel disease.
Literatur
1.
Zurück zum Zitat Sonnenberg A, Turner KO, Genta RM. Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease. Colorectal Dis. 2018;20:813–820.CrossRef Sonnenberg A, Turner KO, Genta RM. Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease. Colorectal Dis. 2018;20:813–820.CrossRef
2.
Zurück zum Zitat Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476.CrossRef Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476.CrossRef
3.
Zurück zum Zitat Sonnenberg A, Genta RM. Inverse association between Helicobacter pylori gastritis and microscopic colitis. Inflamm Bowel Dis. 2016;22:182–186.CrossRef Sonnenberg A, Genta RM. Inverse association between Helicobacter pylori gastritis and microscopic colitis. Inflamm Bowel Dis. 2016;22:182–186.CrossRef
4.
Zurück zum Zitat Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004;53:1235–1243.CrossRef Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004;53:1235–1243.CrossRef
5.
Zurück zum Zitat Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58:163–174.CrossRef Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology. 1970;58:163–174.CrossRef
6.
Zurück zum Zitat Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733–1741.CrossRef Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733–1741.CrossRef
7.
Zurück zum Zitat Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;120:1161–1181.CrossRef Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;120:1161–1181.CrossRef
8.
Zurück zum Zitat Fenoglio-Preiser CM, Noffsinger AE. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Wolters Kluwer; 2007:843–847. Fenoglio-Preiser CM, Noffsinger AE. Gastrointestinal pathology: an atlas and text. 3rd ed. Philadelphia: Wolters Kluwer; 2007:843–847.
9.
Zurück zum Zitat North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.CrossRef North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.CrossRef
10.
Zurück zum Zitat Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst. 1970;44:297–306.PubMed Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst. 1970;44:297–306.PubMed
11.
Zurück zum Zitat Yao X, Smolka AJ. Gastric parietal cell physiology and Helicobacter pylori-induced disease. Gastroenterology. 2019;156:2158–2173.CrossRef Yao X, Smolka AJ. Gastric parietal cell physiology and Helicobacter pylori-induced disease. Gastroenterology. 2019;156:2158–2173.CrossRef
12.
Zurück zum Zitat Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.CrossRef Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.CrossRef
13.
Zurück zum Zitat Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7:849–854.CrossRef Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7:849–854.CrossRef
14.
Zurück zum Zitat Wang MH, Achkar JP. Gene-environment interactions in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2015;31:277–282.CrossRef Wang MH, Achkar JP. Gene-environment interactions in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2015;31:277–282.CrossRef
15.
Zurück zum Zitat Serban DE. Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet? Nutr Clin Pract. 2015;30:760–779.CrossRef Serban DE. Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet? Nutr Clin Pract. 2015;30:760–779.CrossRef
16.
Zurück zum Zitat Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156:2174–2189.CrossRef Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156:2174–2189.CrossRef
17.
Zurück zum Zitat Sonnenberg A, Turner KO, Genta RM. Associations between gastroesophageal histo-pathology and the occurrence of colon polyps (abstract). Gastroenterology. 2019;156:S683.CrossRef Sonnenberg A, Turner KO, Genta RM. Associations between gastroesophageal histo-pathology and the occurrence of colon polyps (abstract). Gastroenterology. 2019;156:S683.CrossRef
Metadaten
Titel
Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease
verfasst von
Amnon Sonnenberg
Kevin O. Turner
Robert M. Genta
Publikationsdatum
27.11.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05972-1

Weitere Artikel der Ausgabe 8/2020

Digestive Diseases and Sciences 8/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.